1.A Study on Left Ventricular Mass in Patients with Hypertension.
Im Jak HONG ; Suk Young PARK ; Hyun Jo MIN ; Kyong Saeng LEE ; Young Woo LEE ; Chang Sup SONG
Korean Circulation Journal 1991;21(4):706-714
Hypertension is a well known causative factor of congestive heart failure and other cardiovascular disease, and usually induce myocardial hypertrophy. Recent study shows that some antihypertensive drugs may reduce the hypertrophied cardiac mass reversibly. And over the past some decades, increasing attention was focused on these drugs. These drugs include methyldopa, angiotensin converting enzyme inhibitor, calcium channel inhibitor, beta-adrenergic blocker, but diuretics and vasodilators were known not to reduce the hypertrophied ventricular mass. In this study, 46 hypertensive patients were managed by captopril, atenolol, or hydrochlorothiazide monotherapy. And wer estimated and follow up LV mass by echocardiography during 3 months. Captopril and atenolol group showed LV mass reduced, but hydrochlorothiazide group did not. LV mass was reduced more in captopril group than in atenolo group. In conclusion, we have been impressed by this study that diuretics monotherapy for hypertension shoud be reconsidered. And we concluded that drugs which can reduce myocardial mass shoud be chosen to control hypertension as a monotherapeutic drug or a additive drug.
Antihypertensive Agents
;
Atenolol
;
Calcium Channels
;
Captopril
;
Cardiovascular Diseases
;
Diuretics
;
Echocardiography
;
Follow-Up Studies
;
Heart Failure
;
Humans
;
Hydrochlorothiazide
;
Hypertension*
;
Hypertrophy
;
Methyldopa
;
Peptidyl-Dipeptidase A
;
Vasodilator Agents
2.A case of pylephlebitis with Streptococcus viridans and Bacteroides fragilis bacteremia secondary to diverticulitis.
Bon Ho KU ; Young Saeng KIM ; Jong Hun KIM ; Yu Kyong CHOI ; Jae Woo YEON ; Seong Gyu LEE ; Sue Yun KIM
Korean Journal of Medicine 2009;76(5):622-626
Pylephlebitis, a septic thrombophlebitis of the portal vein or one of its tributaries, is a life-threatening complication of intra-abdominal infection. The causes of pylephlebitis include acute diverticulitis, appendicitis, acute cholecystitis, necrotizing pancreatitis, inflammatory bowel disease, and bowel perforation. Although pylephlebitis is an unusual complication of diverticulitis, its morbidity and mortality remain high. Therefore, early diagnosis and initiation of adequate antibiotic therapy is important for improving the long-term prognosis of patients suffering from this rare disease. We report a case of pylephlebitis with Streptococcus viridans and Bacteroides fragilis bacteremia secondary to diverticulitis with a review of the literature.
Appendicitis
;
Bacteremia
;
Bacteroides
;
Bacteroides fragilis
;
Cholecystitis, Acute
;
Diverticulitis
;
Early Diagnosis
;
Humans
;
Inflammatory Bowel Diseases
;
Intraabdominal Infections
;
Pancreatitis
;
Portal Vein
;
Prognosis
;
Rare Diseases
;
Streptococcus
;
Stress, Psychological
;
Thrombophlebitis
;
Viridans Streptococci